Louisiana § 46:153.3.2 Medicaid prescription medication for chronic or acute pain; opioid alternatives

Louisiana Statutes

§ 46:153.3.2 — Medicaid prescription medication for chronic or acute pain; opioid alternatives

Louisiana § 46:153.3.2

Title 46Public Welfare and Assistance

This text of Louisiana § 46:153.3.2 (Medicaid prescription medication for chronic or acute pain; opioid alternatives) is published on Counsel Stack Legal Research, covering Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

La. Stat. Ann. § 46:153.3.2 (2026).

Text

§153.3.2. Medicaid prescription medication for chronic or acute pain; opioid alternatives A. Notwithstanding any provision of law to the contrary, a Medicaid managed care organization shall not deny coverage of a nonopioid prescription drug in favor of an opioid prescription drug when a licensed physician has prescribed a nonopioid medication for the treatment of chronic or acute pain. B. The department shall not establish more restrictive or more extensive utilization controls, including but not limited to more restrictive or more extensive prior authorization or step therapy requirements, for clinically appropriate nonopioid drugs than the least restrictive or extensive utilization controls applicable to any clinically appropriate opioid or narcotic drug. C. The department shall:

(1)Pro

Free access — add to your briefcase to read the full text and ask questions with AI

§153.3.2. Medicaid prescription medication for chronic or acute pain; opioid alternatives
A. Notwithstanding any provision of law to the contrary, a Medicaid managed care
organization shall not deny coverage of a nonopioid prescription drug in favor of an opioid
prescription drug when a licensed physician has prescribed a nonopioid medication for the
treatment of chronic or acute pain.
B. The department shall not establish more restrictive or more extensive utilization
controls, including but not limited to more restrictive or more extensive prior authorization
or step therapy requirements, for clinically appropriate nonopioid drugs than the least
restrictive or extensive utilization controls applicable to any clinically appropriate opioid or
narcotic drug.
C. The department shall:
(1) Provide education, awareness, and technical assistance on the advantages of
nonopioid alternative drugs.
(2) Collaborate with political subdivisions, nonprofit organizations, and other state
agencies to seek funding opportunities for educational and healthcare services related to
nonopioid alternatives.
(3) Assist, upon request, political subdivisions that receive opioid grant awards as
a result of any money obtained through a settlement or judgment by the attorney general on
behalf of this state related to opioid litigation involving pharmaceutical supply chain
participants.